The Patient Always Comes First

Championing Neurovascular Innovations to Elevate Lives and Deliver Unparalleled Patient Care Worldwide

Innovating Today for a Healthier Tomorrow

MicroPort NeuroScientific is transforming neurovascular care with groundbreaking innovations. Our cutting-edge solutions, like the Apollo™ Intracranial Arterial Stent System and Tubridge™ Flow-diverting Stent, showcase our commitment to pushing medical technology's boundaries. Join us as we revolutionize patient outcomes with every breakthrough.

ESMINT

September 3rd - 5th

Palais du Pharo, Marseille, France

Join us for the 17th ESMINT Congress, taking place 3–5 September 2025 at the prestigious Palais du Pharo Congress Center in Marseille, France. Organized by the European Society of Minimally Invasive Neurological Therapy (ESMINT), this leading annual event brings together top neurointerventionalists, neurosurgeons, neurologists, and neuroradiologists from Europe and beyond to explore “New Horizons in Neurointerventions” . Over three days, attendees will engage with an impressive scientific program featuring keynote presentations, live moderated sessions, case-based discussions—including the specialty morbi-mortality corner—and practical workshops focused on cutting-edge techniques such as robotics, AI integration, and advanced endovascular therapies.

  • First Commercial Implantations of NUMEN™ Coil of MicroPort NeuroTech Successfully Completed in France

  • MicroPort NeuroTech was Named One of the Top 100 “Specialized and Sophisticated Enterprises 2024” in Shanghai

  • Combination of Engineering with Medicine, the World’s First Clinical Application of MicroPort NeuroTech Percutaneous Neuroprotection for Carotid Artery Remodelling System Completed

  • First Implantation of Tubridge™ Completed in Brazil by MicroPort NeuroTech

Our Team